Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
report update icon

Quarterly report 2026-Q1
added 05-14-2026

Sangamo Therapeutics Interest Expense | SGMO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Sangamo Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
-3.56 M 4.35 M - - - - - - - 887 K 431 K 364 K 82 K - - - 268 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.35 M -3.56 M 402 K

Quarterly Interest Expense Sangamo Therapeutics

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
651 K 107 K -2.49 M -1.16 M -221 K 614 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
651 K -2.49 M -416 K

Interest Expense of other stocks in the Biotechnology industry

Issuer Interest Expense Price % 24h Market Cap Country
Intellia Therapeutics Intellia Therapeutics
NTLA
28.3 M $ 10.02 5.24 % $ 1.09 B usaUSA
Adagene Adagene
ADAG
1.11 M $ 1.8 -10.56 % $ 106 M chinaChina
Pfizer Pfizer
PFE
2.67 B $ 27.4 -0.62 % $ 156 B usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
7 K $ 10.56 -6.26 % $ 4.38 B irlandaIrlanda
ImmuCell Corporation ImmuCell Corporation
ICCC
476 K $ 11.08 -0.81 % $ 100 M usaUSA
Editas Medicine Editas Medicine
EDIT
-2.19 M $ 1.63 -4.68 % $ 145 M usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
1.96 M $ 27.54 -4.24 % $ 1.6 B usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
-14.3 M $ 68.45 1.08 % $ 29.4 B usaUSA
Equillium Equillium
EQ
-76 K $ 1.06 -5.36 % $ 60.7 M usaUSA
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
5.78 M $ 1.32 -5.04 % $ 75.1 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
3.74 M $ 2.42 -1.17 % $ 128 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
2.37 M $ 17.1 -2.79 % $ 2.88 B usaUSA
Atossa Therapeutics Atossa Therapeutics
ATOS
-6 K $ 1.6 -8.86 % $ 13.8 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
1.26 M $ 112.31 -3.84 % $ 7.3 B usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
22.7 M $ 1.29 -2.28 % $ 164 M schweizSchweiz
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
-680 K $ 32.58 -1.21 % $ 1.87 B usaUSA
Ardelyx Ardelyx
ARDX
4.95 M $ 2.99 -2.25 % $ 721 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
58 K $ 0.39 -8.41 % $ 100 M usaUSA
Alector Alector
ALEC
13.2 M $ 2.34 1.52 % $ 241 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
1.6 M $ 1.06 3.43 % $ 56.9 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
16.5 M $ 21.12 -1.26 % $ 6.62 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
459 K $ 4.03 -1.11 % $ 772 M canadaCanada
Agenus Agenus
AGEN
72.4 M $ 5.97 -2.85 % $ 178 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
-2.71 M $ 9.63 -8.02 % $ 2.88 B canadaCanada
Artelo Biosciences Artelo Biosciences
ARTL
194 K $ 1.35 -6.9 % $ 255 K usaUSA
Immatics N.V. Immatics N.V.
IMTX
946 K $ 5.76 -3.19 % $ 705 M germanyGermany
Aptevo Therapeutics Aptevo Therapeutics
APVO
345 K $ 0.4 -2.61 % $ 126 K usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
2.2 M $ 1.22 -2.4 % $ 12.1 M usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
8.51 M $ 3.44 -1.86 % $ 422 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
11.8 M $ 27.46 -2.1 % $ 4.17 B usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
-426 $ 0.83 -8.27 % $ 2.16 M usaUSA
SIGA Technologies SIGA Technologies
SIGA
3.02 M $ 2.4 -9.06 % $ 172 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
399 K $ 7.56 0.4 % $ 351 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
23 K $ 28.3 0.68 % $ 1.32 B usaUSA
Syndax Pharmaceuticals Syndax Pharmaceuticals
SNDX
-1.28 M $ 8.71 -4.16 % $ 755 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
6.34 M $ 3.47 -6.48 % $ 371 M usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
1.27 M $ 0.59 -4.42 % $ 36.2 M usaUSA
Jaguar Health Jaguar Health
JAGX
67 K $ 0.24 -27.06 % $ 560 K usaUSA
Arvinas Arvinas
ARVN
-400 K $ 6.41 -4.9 % $ 454 M usaUSA
Cerus Corporation Cerus Corporation
CERS
3.02 M $ 1.86 -2.37 % $ 355 M usaUSA